Skip to main content

Season 2 Episode 5: Supply Chain Trends & Opportunities for the Life Science Medical Device Industry

Esker

Over last 18 months, companies have experienced significant fluctuations in demand, putting significant pressure on supply chains and making it difficult for those in the life sciences industry to remain competitive to effectively manage cash. That’s why cashflow is now the key focus for supply chain leaders as they look to ensure that they have the most efficient order-to-cash process as possible to minimize the amount of money being tied up in inventory.

In the S2 Episode 5 of Esker On Air, Esker Director of Sales and Business Development Dan Reeve chats with President and CEO of Terso Solutions about current supply chain trends and opportunities for companies in the life science medical device industry to leverage technology to optimize cashflow.

Listen to Episode 5 now!

Esker

As a worldwide leader in AI-driven process automation software, Esker helps financial and customer service departments digitally transform their purchase-to-pay and order-to-cash cycles. Founded in 1985, Esker operates in North America, Latin America, Europe and Asia Pacific with global headquarters in Lyon, France, and U.S. headquarters in Madison, Wisconsin.

Author Photo: 

Subscribe to new posts

 

 

A PROPOSITO DI ESKER

Esker è una multinazionale nata nel 1985 e negli anni ha sviluppato una piattaforma cloud globale che aiuta le aziende a gestire i processi business in modalità digitale. Unica piattaforma cloud che può gestire sia l’automazione del ciclo P2P (supplier management, contract management, procurement, accounts payable, expense management, payment management, sourcing) che O2C (order management, invoice delivery, collection&payment management, claims&deductions, cash allocation, credit management e customer management). Adottiamo tecnologie innovative che ci permettono di integrarci con gli ERP aziendali e in questi anni abbiamo ottenuto riconoscimenti da Gartner, IDC, Ardent Partner e Forrester.


 

Top